Marilena Vrana/LinkedIn
Oct 5, 2025, 11:50
Marilena Vrana: Europe’s Plasma Supply Chain is at a Critical Juncture, and Current Policies are not Equipped to Fix it
Marilena Vrana, Vice President at the Plasma Protein Therapeutics Association (PPTA) Europe, shared a post on LinkedIn:
“Europe’s plasma supply chain is at a critical juncture, and current policies are not equipped to fix it.
In my latest opinion piece The Brussels Times, I break down why plasma-derived medicines require a holistic policy approach – especially as the Critical Medicines Act takes shape.
- Europe’s dependence on US plasma
- Why PDMPs don’t fit policies designed to tackle supply chains of chemically synthesized pharmaceuticals
- The pitfalls of “one-size-fits-all” approach
- The importance of collaboration
If we, Europeans, aim to achieve strategic autonomy and security of medicines supply, our policies must be grounded in reality.
International Plasma Awareness Week, which starts on October 6th, offers the perfect moment to reset Europe’s approach.”

Read more here.
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 17:36Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
-
Jun 24, 2026, 17:22Kavitha Dev: A Low Platelet Count Isn’t Always Critical, But It Should Never Be Ignored
-
Jun 24, 2026, 17:04Recurrent Cervical Internal Carotid Vasospasm Linked to Autosomal Recessive PTGIS Defect – International Journal of Stroke
-
Jun 24, 2026, 16:49Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
-
Jun 24, 2026, 16:40William Wallace: Vitamin C and Collagen Work as One Biological System
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc